Back to search
FDAFDA · Food and drugs·Recall number D-0007-2023

Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-405-16

Published October 12, 2022 · Recall initiated: September 14, 2022

Summary

FDA records drug Class III recall D-0007-2023, published October 12, 2022 and initiated September 14, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Completed; Reported quantity: 2,838 ampules; Lot: Lot # ACB101, Exp 03/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.

What to do

Voluntary: Firm initiated · Letter

Get an email if PHYTONADIONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PHYTONADIONE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA nationwide
Lot
Lot # ACB101, Exp 03/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-405-16 recalled?

Yes. FDA published recall D-0007-2023 on October 12, 2022. Reported hazard: Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PHYTONADIONE.